Session

Lipids 2025: Improving Cardiovascular Health

This session is to provide an update of Lipid management for use in clinical practice. This will include an overview of the current recommendations for screening Lipids across the life span, lifestyle modification, and Lipid therapy for primary and secondary cardiovascular prevention.
Discussion of the current Lipid guidelines including: 2018 Multi-societal. 2022 United States Preventative Taskforce , 2022 therapies, American College of Cardiology Non-Statin therapies, 2023 National Lipid Association and American Society of Preventative Cardiology LDL-C.
Common Lipid disorders, secondary causes of dyslipidemia, and when to refer to the Lipid Clinic for advanced therapies and testing will be reviewed.

Caroline deRichemond, CRNP, CLS, FNLA

Clinical Lipid Specialist, Fellow of the National Lipid Association, Geisinger Cardiology

Actions

Please note that Sessionize is not responsible for the accuracy or validity of the data provided by speakers. If you suspect this profile to be fake or spam, please let us know.

Jump to top